both f-18 fdg-avidity and malignant shape of cervical lymph nodes on pet/ct after total thyroidectomy predict resistance to high-dose i-131 therapy in patients with papillary thyroid cancer

نویسندگان

byung hyun byun department of nuclear medicine, chonnam national university hwasun hospital, hwasun, jeollanam-do, republic of korea

seong young kwon department of nuclear medicine, chonnam national university hwasun hospital, hwasun, jeollanam-do, republic of korea

ari chong department of nuclear medicine, chonnam national university hospital, gwangju, republic of korea

jahae kim department of nuclear medicine, chonnam national university hospital, gwangju, republic of korea

چکیده

objective: resistance of metastatic lymph nodes (lns) to high dose i-131 therapy is associated with high morbidity in patients with differentiated thyroid cancer. we evaluated the role of f-18 fdg pet/ct in the prediction of resistance to high dose i-131 therapy in patients with papillary thyroid cancer. methods: the subjects were 307 patients who underwent total or near total thyroidectomy followed by high dose (5.55-6.66 gbq) i-131 therapy. we divided the patients into three subgroups by visual assessment of regional lns: fdg-avid lns with a malignant shape on ct (pet/ct-positive group), fdg-avid lns with a benign shape on ct (pet/ct-intermediate group) and no fdg-avid lesion (pet/ct-negative group). we measured the maximum suv (suvmax) of fdg-avid lns in each patient. the presence or absence of focal increased uptake of i-131 was evaluated by whole body scan (wbs), and was denoted as wbs-positive group or wbs-negative group, respectively. resistance to therapy was defined as presence of thyroglobulin (tg) in serum (tg ≥1.0 ng/ml) 3-6 months after i-131 therapy. univariate and multivariate analyses were performed to determine the relationship between resistance to i-131 therapy and various clinico-pathologic variables. results: pet/ct-positive, intermediate, and negative groups included 20 (6.5%), 44 (14.3%) and 243 (79.2%) patients, respectively. the mean suvmax was significantly higher in the pet/ct-positive group than that of the pet/ct-intermediate group (4.6 vs. 2.7, p <0.001). univariate analysis revealed that the pet/ct-positive group (p <0.001), t2-4 stage (p <0.001), n1b stage (p = 0.001), lower dose (5.55 gbq) of i-131 (p <0.001), and the wbs-positive group (p = 0.029) were associated with resistance to therapy. in multivariate analysis, the pet/ct-positive group, lower dose of i-131, n1b stage, and t2-4 stage remained significant with odds ratios of 10.07 (p <0.001), 3.82 (p <0.001), 3.58 (p = 0.001), and 2.53 (p = 0.009), respectively. conclusion: fdg-avidity and malignant shape of cervical lns on pre-therapy fdg pet/ct were a strong risk factors predicting resistance to high dose i-131 therapy. a lower dose of administered i-131 (5.55 gbq) and more extensive tumors (t2-4 and n1b) were also associated with resistance to high dose i-131 therapy.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Both F-18 FDG-avidity and Malignant Shape of Cervical Lymph Nodes on PET/CT after Total Thyroidectomy Predict Resistance to High-dose I-131 Therapy in Patients with Papillary Thyroid Cancer

Objective: Resistance of metastatic lymph nodes (LNs) to high dose I-131 therapy is associated with high morbidity in patients with differentiated thyroid cancer. We evaluated the role of F-18 FDG PET/CT in the prediction of resistance to high dose I-131 therapy in patients with papillary thyroid cancer. Methods: The subjects were 307 patients who underwent total or near total thyroidectomy fol...

متن کامل

Asia Oceania Journal of Nuclear Medicine and Biology

keyword: F-18 FDG PET/CT, resistance to I-131 therapy, cervical lymph node, papillary thyroid cancer Objective: Resistance of metastatic lymph nodes (LNs) to high dose I-131 therapy is associated with high morbidity in patients with differentiated thyroid cancer. We evaluated the role of F-18 FDG PET/CT in the prediction of resistance to high dose I-131 therapy in patients with papillary thyroi...

متن کامل

Suspicious cervical lymph nodes detected after thyroidectomy for papillary thyroid cancer usually remain stable over years in properly selected patients.

CONTEXT The risk of loco-regional recurrence in papillary thyroid cancer (PTC) patients ranges from 15-30%. However, the clinical significance of small-volume loco-regional recurrence detected by highly sensitive ultrasonography is unclear. OBJECTIVE Our objective was to describe the natural history of abnormal cervical lymph nodes (LN) diagnosed after initial treatment. DESIGN We conducted...

متن کامل

Sonographic evaluation of cervical lymph nodes in papillary thyroid cancer.

Sonography is the modality of choice for imaging cervical lymph nodes in patients with papillary thyroid cancer, both before surgery and for postoperative surveillance. Sonography is also an invaluable tool to guide fine-needle aspiration of abnormal nodes. Microcalcifications, cystic changes, abnormal morphology, and disordered vascularity are features of metastatic nodal involvement with papi...

متن کامل

Normalization of lymphocyte count after high ablative dose of I-131 in a patient with chronic lymphoid leukemia and secondary papillary carcinoma of the thyroid. Case report

The authors report the case of a 70-year-old male patient with chronic lymphoid leukemia who presented subsequently a papillary carcinoma of the thyroid with metastases to regional lymph nodes. The patient was treated with surgical thyroidectomy with regional and cervical lymph node excision and radioiodine therapy (I-131). The protocolar control scintigraphy 4 days after the radioactive dose s...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
asia oceania journal of nuclear medicine and biology

جلد ۱، شماره ۱، صفحات ۶-۱۳

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023